These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1116 related articles for article (PubMed ID: 14872477)
1. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial. Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis. Cohen SB; Cheng TT; Chindalore V; Damjanov N; Burgos-Vargas R; Delora P; Zimany K; Travers H; Caulfield JP Arthritis Rheum; 2009 Feb; 60(2):335-44. PubMed ID: 19180516 [TBL] [Abstract][Full Text] [Related]
3. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study. Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J; Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810 [TBL] [Abstract][Full Text] [Related]
4. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503 [TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Emery P; Fleischmann R; Filipowicz-Sosnowska A; Schechtman J; Szczepanski L; Kavanaugh A; Racewicz AJ; van Vollenhoven RF; Li NF; Agarwal S; Hessey EW; Shaw TM; Arthritis Rheum; 2006 May; 54(5):1390-400. PubMed ID: 16649186 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Ogrendik M Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134 [TBL] [Abstract][Full Text] [Related]
8. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester GR; Cravets MW; Hessey EW; Shaw T; Totoritis MC; Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627 [TBL] [Abstract][Full Text] [Related]
9. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies. Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612 [TBL] [Abstract][Full Text] [Related]
10. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study. Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A; Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217 [TBL] [Abstract][Full Text] [Related]
13. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851 [TBL] [Abstract][Full Text] [Related]
14. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358 [TBL] [Abstract][Full Text] [Related]
15. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102 [TBL] [Abstract][Full Text] [Related]
16. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials. Doyle MK; Rahman MU; Han C; Han J; Giles J; Bingham CO; Bathon J Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645 [TBL] [Abstract][Full Text] [Related]
17. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial. Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730 [TBL] [Abstract][Full Text] [Related]
18. A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate. Genovese MC; Lee E; Satterwhite J; Veenhuizen M; Disch D; Berclaz PY; Myers S; Sides G; Benichou O Ann Rheum Dis; 2013 Sep; 72(9):1453-60. PubMed ID: 23599435 [TBL] [Abstract][Full Text] [Related]
19. A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis. Abe T; Takeuchi T; Miyasaka N; Hashimoto H; Kondo H; Ichikawa Y; Nagaya I J Rheumatol; 2006 Jan; 33(1):37-44. PubMed ID: 16395748 [TBL] [Abstract][Full Text] [Related]
20. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial. Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]